Transparency Market

Research
Dermatology Diagnostic Devices and Therapeutics
Market - Global Industry Analysis, Size, Share, Growth,
Trends and Forecast 2015 - 2023

Published Date
03-02-2016

105 Page Report

Buy Now

Request Sample

Press Release
Dermatology Diagnostic Devices and Therapeutics Market to Reach US$
21.1 bn by 2023 as Acute and Chronic Skin Disorders Rise

Transparency Market Research

State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com

Dermatology Diagnostic Devices

and Therapeutics Market

REPORT DESCRIPTION

Dermatology Diagnostic Devices and Therapeutics Market - Global Industry Analysis, Size,
Share, Growth, Trends and Forecast 2015 - 2023
According to a new market report published by Transparency Market Research Dermatology Diagnostic
Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015
- 2023, the global dermatology diagnostic devices market was valued at US$ 0.6 Mn in 2014 and is
projected to expand at a CAGR of 6.9% from 2015 to 2023 to reach US$ 1.0 Bn in 2023. Similarly, the
global dermatology therapeutics market was valued at US$ 17.5 Bn in 2014 and is projected to expand at
a CAGR of 1.9% from 2013 to 2018 and 1.6% from 2018 to 2023 to reach US$ 20.1 Bn in 2023.
Browse the full report at:
:http://www.transparencymarketresearch.com/dermatology-diagnostic-devices-therapeutics-market.html
Dermatology is a branch of medical science that deals with examination and treatment of various disorders
and diseases related to the skin, hair, nails, including its surgical aspect. The stakeholders of this market
report comprise established original equipment and pharmaceutical product manufacturers, product
distributors, and new players who wish to enter the global dermatology diagnostic devices and
therapeutics market.
This report provides a complete analysis of the global dermatology diagnostic devices and therapeutics
market and helps in recognizing several governing factors that impact the market both positively and
negatively. Executive summary of the report captures comprehensive insights about every segment
considered in this study. It includes a market snapshot offering an insight into the current scenario of the
dermatology diagnostic device and dermatology market in terms of current and future market size along
with growth rate.
The market overview segment provides thorough information on the trends in the usage pattern of various
diagnostic devices and therapeutics for dermatology, such as drivers, restraints, and growth opportunities
that presently regulate the dynamics of the overall market. Competitive analysis tools such as Porters Five
Forces analysis and market attractiveness analysis have also been incorporated in this study to provide

Transparency Market Research

Dermatology Diagnostic Devices

and Therapeutics Market

analysis about the level of competition within the dermatology diagnostic devices and therapeutics
market. Competitive intelligence tools such as market attractiveness analysis have also been included in
the market overview section of the report to deliver a clear understanding of the most attractive and
fastest growing device segment, drug class and region globally for dermatology diagnostic devices and
therapeutics.

Get Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?

flag=S&rep_id=8908
Market share analysis thus provided in this study is in context with major players of dermatology
diagnostic devices and dermatology therapeutics operating in the market; this would help new players to
understand the key business models and geographical presence and identify the specific product lines of
existing companies to establish a strong presence in the dermatology diagnostic devices and therapeutics
market. Furthermore, the research comprises a chapter on pipeline analysis for this industry that includes
tabular representation of phase I and phase II candidates along with sales forecast potential drugs that are
undergoing phase III clinical trials and are expected to be marketed during the forecast period.
The global dermatology diagnostic devices and therapeutics market has been segmented based on various
dermatology diagnostic devices, drug classes used for treating dermatology disorders, and geographies.
Based on dermatology diagnostic products the market has been categorized into dermatoscopes,
microscopes & trichoscopes, and imaging equipment. Based on drug class the dermatology therapeutics
market has been segmented into antibacterials, antifungal agents, antiviral agents, corticosteroids,
retinoids, immunosuppresants, biologics. The market size for the period from 2013 to 2023 has been
provided for each of the devices and therapeutics categories mentioned above in terms of US$ Mn. Along
with the market size that was projected considering 2014 as the base year and 2013 as the historical year,
the CAGR (%) of each market segment for the forecast period from 2015 to 2023 (for therapeutics forecast
period is from 2013 to 2018 and 2018 to 2023) has also been provided.
Geographically, the dermatology diagnostic devices and therapeutics market has been segmented into
North America, Europe, Asia Pacific, Latin America, the Middle East & North Africa, and Rest of the World.
North America has been further segmented into the U.S. and Canada; Europe into Germany, the U.K. and
Rest of Europe; Asia Pacific into China, Japan, India, Australia, and Rest of Asia Pacific; Latin America into

Transparency Market Research

Dermatology Diagnostic Devices

and Therapeutics Market

Brazil and Rest of Latin America; Middle East & North Africa (MENA) into Egypt, Kuwait, UAE, Saudi Arabia,
and rest of MENA; and Rest of the world. The market revenue of dermatology diagnostic devices and
therapeutics for each geographical region for 2014 and 2023 along with forecast from 2015 to 2023 in
respective regions in terms of USD Mn, has been explained in the geography section of the report.
This market study concludes with profiles of key players in the global dermatology diagnostic devices and
dermatology market. The report summarizes the companies in terms of overview, financial overview,
product and services portfolio, key business strategies, and recent developments. The major players
profiled in the section are Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V.,
Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc (Stiefel Laboratories, Inc.), LEO Pharma
A/S, Michelson Diagnostics Ltd., Novartis International AG, and Valeant Pharmaceuticals International, Inc.
The global dermatology diagnostic devices and therapeutics market has been segmented as follows:
Dermatology Diagnostic Devices Market, by Products

Dermatoscopes

Microscopes and Trichoscopes

Imaging Equipment

Dermatology Therapeutics Market, by Drug Class

Antibacterials

Antifungal Agents

Antiviral Agents

Corticosteroids

Retinoids

Immunosuppresants

Transparency Market Research

Dermatology Diagnostic Devices

and Therapeutics Market

Biologics

Dermatology Therapeutics Market: Pipeline Overview, Phase 1, 2, and 3

Tabular Representation: Phase 1 and Phase 2 Candidates

Pipeline Analysis and Forecast: Phase 3

LAS41008

Ixekizumab

Dupilumab

CD5789

IDP-118

Dermatology Diagnostic Devices and Therapeutics Market, by Geography

North America

U.S.

Canada

Europe

Germany

U.K.

Rest of Europe

Asia Pacific (APAC)

China

Transparency Market Research

Dermatology Diagnostic Devices

and Therapeutics Market

Japan

India

Australia

Rest of Asia Pacific

Latin America

Brazil

Rest of Latin America

Middle East & North Africa (MENA)

Egypt

Kuwait

UAE

Saudi Arabia

Rest of MENA

Rest of the World (RoW)

Browse Full Press Release @ http://www.transparencymarketresearch.com/pressrelease/dermatologydiagnostic-devices-therapeutics-market.htm

Transparency Market Research

Dermatology Diagnostic Devices

and Therapeutics Market

TABLE OF CONTENT

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, By Revenue,
20132023 (US$ Mn)
2.2 Global Dermatology Diagnostic Devices Market, by Product, 2014 (US$ Mn)
2.3 Global Dermatology Therapeutics Market, by Drug Class, 2014 (US$ Mn)
2.4 Global Market Share by Geography (Diagnostic Devices), 2014 and 2023 (Value %)
2.5 Global Market Share by Geography (Therapeutics), 2014 and 2023 (Value %)
2.6 Dermatology Diagnostic Devices Market Snapshot
2.7 Dermatology Therapeutics Market Snapshot
Chapter 3 Dermatology Diagnostic Devices and Therapeutics Market Overview
3.1 Market Overview
3.2 Market Drivers
3.2.1 Driver 1 - Rising prevalence of acute and chronic skin disorders
3.2.2 Driver 2 - Changing patient pool demographics and increasing geriatric population
3.2.2.1 Percentage of Population (for U.S., China, Japan, and India) over the age of 65: 19802050
3.2.2.2 Global Percentage Change in the Worlds Population by Age: 2010 2050

Transparency Market Research

Dermatology Diagnostic Devices

and Therapeutics Market

3.3 Restraints
3.3.1 Restraint 1 - Implementation of the Affordable Care Act and medical device tax
3.3.2 Restraint 2 -Patent expirations of major drugs during the forecast period expected to impede
market growth
3.4 Opportunities
3.4.1 Opportunity 1 - Disposable income and growing patient pool in emerging markets
3.5 Porters Five Forces Analysis
3.6 Company Market Share
3.7 Market Attractiveness Analysis
3.8 Overview of Skin Diseases
Chapter 4 Market Segmentation By Products
4.1 Introduction
4.1.1 Global Dermatology Diagnostic Devices Market, by Product, 20132023 (US$ Mn)
4.2 Global Dermatoscopes Market Revenue for Dermatology Diagnostic, 20132023 (US$ Mn)
4.3 Global Microscopes and Trichoscopes Market Revenue for Dermatology Diagnostic, 20132023 (US$
Mn)
4.4 Global Imaging Equipment Market Revenue for Dermatology Diagnostic, 20132023 (US$ Mn)
Chapter 5 Market Segmentation By Drug Class
5.1 Introduction
5.1.1 Global Dermatology Therapeutics Market, by Drug Class, 20132023 (US$ Mn)
5.2 Global Antibacterials for Dermatology Market Revenue, 20132023 (US$ Mn)
5.3 Global Antifungal Agents for Dermatology Market Revenue, 20132023 (US$ Mn)
5.4 Global Antiviral Agents for Dermatology Market Revenue, 20132023 (US$ Mn)
5.5 Global Corticosteroids for Dermatology Market Revenue, 20132023 (US$ Mn)

Transparency Market Research

Dermatology Diagnostic Devices

and Therapeutics Market

5.6 Global Retinoids for Dermatology Market Revenue, 20132023 (US$ Mn)
5.7 Global Immunosuppresants for Dermatology Market Revenue, 20132023 (US$ Mn)
5.8 Global Biologics for Dermatology Market Revenue, 20132023 (US$ Mn)
Chapter 6 Market Segmentation By Pipeline Assessment
6.1 Global Dermatology Therapeutics Market: Pipeline Overview, Phase I, II,and III
6.2 Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2023 (US$
Mn)
Chapter 7 Market Segmentation By Region
7.1 Overview
7.1.1 Global Dermatology Diagnostic Devices Market Revenue, by Geography, 20132023 (US$ Mn)
7.1.2 Global Dermatology Therapeutics Market Revenue, by Geography, 20132023 (US$ Mn)
7.2 North America
7.2.1 North America Dermatology Diagnostic Devices Market Revenue, by Country, 20132023 (US$
Mn)
7.2.2 North America Dermatology Therapeutics Market Revenue, by Country, 20132023 (US$ Mn)
7.3 Europe
7.3.1 Europe Dermatology Diagnostic Devices Market Revenue, by Country, 20132023 (US$ Mn)
7.3.2 Europe Dermatology Therapeutics Market Revenue, by Country, 20132023 (US$ Mn)
7.4 Asia Pacific
7.4.1 APAC Dermatology Diagnostic Devices Market Revenue, by Country, 20132023 (US$ Mn)
7.4.2 APAC Dermatology Therapeutics Market Revenue, by Country, 20132023 (US$ Mn)
7.5 Latin America
7.5.1 Latin America Dermatology Diagnostic Devices Market Revenue, by Country, 20132023 (US$ Mn)
7.5.2 Latin America Dermatology Therapeutics Market Revenue, by Country, 20132023 (US$ Mn)

Transparency Market Research

Dermatology Diagnostic Devices

and Therapeutics Market

7.6 Middle East & North Africa

7.6.1 MENA Dermatology Diagnostic Devices Market Revenue, by Country, 20132023 (US$ Mn)
7.6.2 MENA Dermatology Therapeutics Market Revenue, by Country, 20132023 (US$ Mn)
7.7 Rest of the World
7.7.1 RoW Dermatology Diagnostic Devices Market Revenue, 20132023 (US$ Mn)
7.7.2 RoW Dermatology Therapeutics Market Revenue, 20132023 (US$ Mn)
Chapter 8 Historical Snapshot and Current Trends
Chapter 9 Company Profiles
9.1 Agfa-Gevaert N.V.
9.2 Astellas Pharma, Inc.
9.3 Cutera, Inc.
9.4 Dino-Lite Europe/IDCP B.V.
9.5 Galderma S.A.
9.6 Genentech, a Roche Company
9.7 GlaxoSmithKline plc (Stiefel Laboratories, Inc.)
9.8 LEO Pharma A/S
9.9 Michelson Diagnostics Ltd.
9.10 Novartis International AG
9.11 Valeant Pharmaceuticals International, Inc.

About Us
Transparency Market Research is a market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.

Transparency Market Research

10

Dermatology Diagnostic Devices

and Therapeutics Market

Contact

Transparency Market Research

90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Transparency Market Research

11